Hamilton Thorne (HTLZF) announced the appointment, of Dr. Ekaterina Torchilin as its new President and CEO, effective January 15, 2024. Dr. Torchilin is succeeding David Wolf, who is retiring as President and CEO. Mr. Wolf will continue to serve the Company as Executive Chairman. Dr. Torchilin will also join the Hamilton Thorne Board of Directors upon assuming the CEO role. Dr. Torchilin is currently the President of the Biologicals and Chemicals Division at Thermo Fisher Scientific (TMO).
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on TMO: